RESUMEN
The Pharmacokinetic/Pharmacodynamic (PK/PD) relationship of antimicrobial drugs (AMD) for surgical prophylaxis has been poorly studied, hampering evidence-based decision making around AMD dosing and timing. Our objective is to use PK/PD principles to inform (1) the timing of administration and (2) the interval for re-administration of AMD used peri-operatively in dogs. Raw plasma concentrations of cefazolin, cefuroxime, cefalexin, amoxicillin and ampicillin were retrieved from original intravenous studies performed in dogs. E. coli and methicillin-susceptible staphylococci were identified as possible intraoperative contaminants and their epidemiological cut-offs (ECOFF) were retrieved from the EUCAST database. Individual PK data were refitted with non-linear mixed effect models (Phoenix®). We performed Monte Carlo simulation to compute i) the 95th percentile of time of peak concentration in the peripheral compartment (informing timing between administration and first incision) and ii) the duration for which at least 90% of dogs maintain a free plasma concentration above ECOFF (informing timing of re-administration: 1.5-4â¯h). Cefazolin (22-25â¯mg/kg), cefuroxime (20â¯mg/kg), cefalexin (15â¯mg/kg) and amoxicillin (16.7â¯mg/kg) reached peak peripheral concentrations within 30â¯min, but ampicillin (20â¯mg/kg) required 82â¯min, respectively. For methicillin-susceptible staphylococci, cefazolin and cefuroxime require re-administration every 2â¯h, whereas cefalexin and both amoxicillin and ampicillin can be readministered every 3 and 4â¯h, respectively. For E. coli, only cefazolin provided adequate perioperative coverage with 2-hourly administration, where cefuroxime and cefalexin failed uniformly. Alternatively, ampicillin and amoxicillin (critically ill dogs) may cover E. coli contaminations, but only if readministered every 1.5â¯h. These PK-derived conclusions provide a rationale for perioperative AMD administration timing.
Asunto(s)
Antibacterianos , Profilaxis Antibiótica , beta-Lactamas , Perros , Animales , Antibacterianos/farmacocinética , Antibacterianos/administración & dosificación , Profilaxis Antibiótica/veterinaria , beta-Lactamas/farmacocinética , beta-Lactamas/administración & dosificación , Enfermedades de los Perros/prevención & control , Enfermedades de los Perros/tratamiento farmacológico , Infección de la Herida Quirúrgica/veterinaria , Infección de la Herida Quirúrgica/prevención & control , Escherichia coli/efectos de los fármacos , Método de MontecarloRESUMEN
Surgical antimicrobial prophylaxis (SAP) is widely used to reduce the risk of surgical site infections (SSI), but there is uncertainty as to what the proportion of SSI reduction is. Therefore, it is difficult for surgeons to properly weigh the costs, risks and benefits for individual patients when deciding on the use of SAP, making it challenging to promote antimicrobial stewardship in primary practice settings. The objective of this study was to map the veterinary evidence focused on assessing the effect of SAP on SSI development and in order to identify surgical procedures with some research evidence and possible knowledge gaps. In October 2021 and December 2022, Scopus, CAB Abstracts, Web of Science Core Collection, Embase and MEDLINE were systematically searched. Double blinded screening of records was performed to identify studies in companion animals that reported on the use of SAP and SSI rates. Comparative data were available from 34 out of 39123 records screened including: eight randomised controlled trials (RCT), 23 cohort studies (seven prospective and 16 retrospective) and three retrospective case series representing 12476 dogs and cats in total. Extracted data described peri- or post-operative SAP in nine, and 25 studies, respectively. In the eight RCTs evaluating SAP in companion animals, surgical procedure coverage was skewed towards orthopaedic stifle surgeries in referral settings and there was large variation in SAP protocols, SSI definitions and follow-up periods. More standardized data collection and agreement of SSI definitions is needed to build stronger evidence for optimized patient care.